Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 204

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Cellular Zinc and Redox Buffering Capacity of Metallothionein/Thionein in Health and Disease

Open access
Maret, Wolfgang, Krężel, Artur · 2007 · Molecular Medicine

Abstract

Zinc is involved in virtually all aspects of cellular and molecular biology as a catalytic, structural, and regulatory cofactor in over 1000 proteins. Zinc binding to proteins requires an adequate supply of zinc and intact molecular mechanisms for redistributing zinc ions to make them available at the right time and location. Several dozen gene products participate in this process, in which interactions between zinc and sulfur donors determine the mobility of zinc and establish coupling between cellular redox state and zinc availability. Specifically, the redox properties of metallothionein and its apoprotein thionein are critical for buffering zinc ions and for controlling fluctuations in the range of picomolar concentrations of "free" zinc ions in cellular signaling. Metallothionein and other proteins with sulfur coordination environments are sensitive to redox perturbations and can render cells susceptible to injury when oxidative stress compromises the cellular redox and zinc buffering capacity in chronic diseases. The implications of these fundamental principles for zinc metabolism in type 2 diabetes are briefly discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2119/2007-00036.maret

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 44

  1. Hambidge M. (2000) Human zinc deficiency J. Nutr. 130:1344S–9S. · DOI · Paper page
  2. Sandstead HH, Frederickson CJ, Penland JG. (2000) History of zinc related to brain function. J. Nutr. 130:496S–502S. · DOI · Paper page
  3. Frederickson CJ, Koh J-Y, Bush AI. (2005) The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 6:449–62. · DOI · Paper page
  4. Fong LYY, Jiang YB, Farber JL. (2006) Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice. Carcinogenesis. 27:1489–96. · DOI
  5. Wang K et al. (2002) A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet. 71:66–73. · DOI · Paper page
  6. Küry S et al. (2002) Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat. Genet. 31:239–40. · DOI · Paper page
  7. Chowanadisai W, Lönnerdal B, Kelleher SL. (2006) Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J. Biol. Chem. 281:39699–707. · DOI · Paper page
  8. Cipriano C et al. (2006) Polymorphisms in MT1a gene coding region are associated with longevity in Italian Central female population. Biogerontology. 7:357–65. · DOI
  9. Sensi SL, Jeng JM. (2004) Rethinking the excitotoxic ionic milieu: the emerging role of Zn2+ in ischemic neuronal injury. Curr. Mol. Med. 4:87–111. · DOI
  10. Jacob C, Maret W, Vallee BL. (1998) Control of zinc transfer between thionein, metallothionein and zinc proteins. Proc. Natl. Acad. Sci. USA. 95:3489–94. · DOI · Paper page
  11. Pattanaik A et al. (1994) Basal metallothionein in tumors: Widespread presence of apoprotein. J. Inorg. Biochem. 54:91–105. · doi:10.1016/0162-0134(94)80023-5
  12. Yang Y, Maret W, Vallee BL. (2001) Differential fluorescence labeling of cysteinyl clusters uncovers high tissue levels of thionein. Proc. Natl. Acad. Sci. USA. 98:5556–9. · doi:10.1073/pnas.101123298
  13. Kreżel A, Maret W. (2007) Different redox states of metallothionein/thionein in biological tissue. Biochem. J. 402:551–8. · DOI
  14. Maret W et al. (1999) Inhibitory sites in enzymes: Zinc removal and reactivation by thionein. Proc. Natl. Acad. Sci. USA. 96:1936–40. · DOI · Paper page
  15. Maret W, Vallee BL. (1998) Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. USA. 95:3478–82. · DOI · Paper page
  16. Maret W. (2006) Zinc coordination environments in proteins as redox sensors and signal transducers. Antioxid. Redox Signal. 8:1419–41. · DOI · Paper page
  17. Haase H, Maret W. (2004) A differential assay for the reduced and oxidized states of metallothionein and thionein. Anal. Biochem. 333:19–26. · doi:10.1016/j.ab.2004.04.039
  18. Feng W et al. (2006) Metallothionein disulfides are present in metallothionein-overexpressing transgenic mouse heart and increase under conditions of oxidative stress. J. Biol. Chem. 281:681–7. · DOI
  19. Kreżel A, Maret W. (2006) Zinc buffering capacity of a eukaryotic cell at physiological pZn. J. Biol. Inorg. Chem. 11:1049–62. · DOI · Paper page
  20. Kreżel A, Hao Q Maret W. (2007) The zinc/thiolate redox biochemistry of metallothionein and the control of zinc ion fluctuations in cell signaling. Arch. Biochem. Biophys. DOI:10.1016/j.abb.2007.02.017. · DOI · Paper page
  21. Maret W. (2004) Protein interface zinc sites: A role of zinc in the supramolecular assembly of proteins and in transient protein-protein interactions, in: Messerschmidt, A., Bode, W., and Cygler, M., eds., Handbook of Metalloproteins, Vol. 3, pp. 432–41, John Wiley, Chichester.
  22. Kirlin WG et al. (1999) Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic. Biol. Med. 27:1208–18. · DOI · Paper page
  23. Woo ES, Monks A, Watkins SC, et al. (1997) Diversity of metallothionein content and sub-cellular localization in the National Cancer Institute tumor panel. Cancer Chemother. Pharmacol. 4:61–8. · doi:10.1007/s002800050708
  24. Haase H et al. (2006) Flow cytometric measurements of labile zinc in peripheral blood mononuclear cells. Anal. Biochem. 352:222–30. · DOI · Paper page
  25. Maret W. (2005) Zinc and diabetes. BioMetals. 18:293–4. · DOI
  26. Chimienti F, Favier A, Seve M. (2005) ZnT-8, a pancreatic beta-cell-specific transporter. BioMetals. 18:313–7. · DOI
  27. Roussel A-M et al. (2003) Antioxidant effects of zinc supplementation in Tunisians with type 2 diabetes mellitus. J. Am. Coll. Nutr. 22:316–1. · DOI · Paper page
  28. Schott-Ohly P et al. (2004) Prevention of spontaneous and experimentally induced diabetes in mice with zinc sulfate-enriched drinking water is associated with activation and reduction of NF-κB and AP-1 in islets, respectively. Exp. Biol. Med. 229:1177–85. · DOI
  29. Adachi Y et al. (2006) Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes. Biochem. Biophys. Res. Commun. 351:165–70. · DOI
  30. Ayaz M, Turan B. (2006) Selenium prevents diabetes-induced alterations in [Zn2+]i and metal-lothionein level of rat heart via restoration of cell redox cycle. Am. J. Physiol Heart Circ. Physiol. 290:1071–80. · DOI
  31. Chen Y, Maret W. (2001) Catalytic selenols couple the redox cycles of metallothionein and glutathione. Eur. J. Biochem. 268:3346–53. · DOI
  32. Wang J et al. (2006) Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation. 113:544–54. · DOI · Paper page
  33. Kang YJ. (1999) The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med. 222:263–73. · DOI · Paper page
  34. Barbato JC et al. (2007) Targeting of metallothionein by L-homocysteine. A novel mechanism for disruption of zinc and redox homeostasis. Arterioscler. Thromb. Vasc. Biol. 27:49–54. · DOI
  35. Scheede-Bergdahl C et al. (2005) Metallothionein-mediated antioxidant defense system and its response to exercise training are impaired in human type 2 diabetes. Diabetes. 54:3089–94. · DOI
  36. Beattie et al. (1998) Obesity and hyperleptinemia in metallothionein (-I and -II) null mice. Proc. Natl. Acad. Sci. USA. 95:358–63. · DOI · Paper page
  37. Hao Q, Maret W. (2006) Aldehydes release zinc from proteins. A pathway from oxidative stress/lipid peroxidation to cellular functions of zinc. FEBS J. 273:4300–10. · DOI
  38. Haase H, Maret W. (2003) Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp. Cell Res. 291:289–98. · DOI · Paper page
  39. Haase H, Maret W. (2005) Fluctuations of cellular, available zinc modulate phosphorylation signaling. J. Trace Elem. Med. Biol. 19:37–42. · DOI
  40. Haase H, Maret W. (2005) Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. BioMetals 18:333–8. · DOI · Paper page
  41. St. Croix CM et al. (2005) Nitric oxide and zinc homeostasis in acute lung injury. Proc. Am. Thor. Soc. 2:236–42. · DOI
  42. Frederickson CJ, Maret W, Cuajungco MP. (2004) Zinc and excitotoxic brain injury: A new model. Neuroscientist. 10:18–25. · DOI
  43. Maret W, Sandstead HH. (2006) Zinc requirements and the risks and benefits of zinc supplementation. J. Trace Elem. Med. Biol. 20:3–18. · DOI · Paper page
  44. Kang YJ, Zhou Z. (2005) Zinc prevention and treatment of alcoholic liver disease. Mol. Asp. Med. 26:391–404. · DOI

Cited by

See all 204

Metadata

Authors
Maret, W., & Krężel, A.
Venue
Molecular Medicine
Published
2007-07
Volume
13
Issue
7-8
Pages
371-375
ISSN
  • 1076-1551 (ISSN-L)
  • 1528-3658
OpenAlex
W4252413772
Cited by
204
References
1
FWCI
10.76
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cellular Zinc and Redox Buffering Capacity of Metallothionein/Thionein in Health and Disease. https://app.cochat.ai/papers/10.2119/2007-00036.maret
The paper
Maret, W., & Krężel, A. (2007). Cellular Zinc and Redox Buffering Capacity of Metallothionein/Thionein in Health and Disease. Molecular Medicine. https://doi.org/10.2119/2007-00036.maret

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.